List your tool

8 alternatives · updated Jul 2026

The best InHEART alternatives in 2026

8 tools that do the job InHEART does. Each one is measured against InHEART on price, free plan and our rating, so you can see what you gain by switching.

Shortlist by what you need

Start here if you know why you are leaving InHEART.

  1. Want the closest match?

    AISAP

    Most similar to InHEART in what it does, its category and its price.

    Visit (opens AISAP in a new tab)

  2. Want the lowest price?

    Ezra AI

    From $499/mo, the lowest starting price here.

    Visit (opens Ezra AI in a new tab)

  3. Want the best rated?

    Viz.ai

    Rated 4.4 out of 5 in our review, against 4.2 for InHEART.

    Visit (opens Viz.ai in a new tab)

At a glance

Green means better than InHEART, red means worse. Prices are starting prices per month.

ToolOur ratingStarts atFree planBest forCompare
InHEARTBaseline4.2Not listedNoInHEART builds AI-generated 3D digital twins of the heart to plan cardiac ablation and predict cardiac risk.
AISAP4.1−0.1Not listedNoAn FDA-cleared AI platform that reads cardiac ultrasound images at the bedside in real time.vs InHEART
CoLumbo4.2SameNot listedNoCoLumbo analyzes lumbar spine MRI scans and pre-populates radiology reports with FDA-cleared AI segmentation.vs InHEART
InformAI3.9−0.3Not listedNoHouston healthcare AI company with an FDA-cleared radiation therapy dose-planning tool and transplant and sinus-imaging products.vs InHEART
Viz.ai4.4+0.2Not listedNoTrusted by 2,000+ hospitals, cutting stroke transfer time by 44% in 2026 clinical datavs InHEART
Artera4.4+0.2Not listedNoFDA-cleared multimodal AI that reads biopsy images and clinical data to guide cancer therapy decisions.vs InHEART
PathAI4.3+0.1Not listedNoFirst AI pathology platform FDA-cleared for primary diagnosis, now deployed nationwide via Labcorpvs InHEART
Ezra AI4.1−0.1$499/moNoFull-body MRI screening service that uses AI to flag early signs of cancer across up to 13 organs.vs InHEART
Oatmeal Health3.3−0.9Not listedNoAI reads 3D low-dose CT scans and risk-stratifies lung nodules (AUROC 0.94, trained on 100,000+ scans) - already deployed across underserved health centers in 4 states.vs InHEART

The alternatives in detail

In order of how closely each one matches InHEART.

  1. AISAP

    4.1Not listed

    vs InHEART−0.1

    An FDA-cleared AI platform that reads cardiac ultrasound images at the bedside in real time.

    • Real-time AI interpretation of cardiac ultrasound images at the bedside
    • FDA clearance in the CADx pathway for structural heart disease diagnosis via POCUS
    • Structured, auto-generated reporting that cuts documentation time

    FDA clearance gives it regulatory standing competitors without clearance lack

    Pricing is entirely custom and undisclosed, making budget comparison hard upfront

    Visit AISAP (opens AISAP in a new tab)ReviewCompare with InHEART

  2. CoLumbo

    4.2Not listed

    vs InHEARTSame

    CoLumbo analyzes lumbar spine MRI scans and pre-populates radiology reports with FDA-cleared AI segmentation.

    • Automated vertebra and disc segmentation on lumbar spine MRI
    • Pre-populated structured radiology reports
    • 3D video reconstruction of the spine

    Regulatory clearance across three major markets signals clinical rigor

    Pricing is not public and requires direct engagement with the company

    Visit CoLumbo (opens CoLumbo in a new tab)ReviewCompare with InHEART

  3. InformAI

    3.9Not listed

    vs InHEART−0.3

    Houston healthcare AI company with an FDA-cleared radiation therapy dose-planning tool and transplant and sinus-imaging products.

    • RadOncAI radiation therapy dose planning with FDA 510(k) clearance
    • Focus on head and neck cancer treatment planning
    • TransplantAI donor-recipient informatics for transplant decisions

    One product has FDA 510(k) clearance, a meaningful regulatory milestone

    Only RadOncAI is described as cleared; the other products are research or in development

    Visit InformAI (opens InformAI in a new tab)ReviewCompare with InHEART

  4. Viz.ai

    4.4Not listed

    vs InHEART+0.2

    Trusted by 2,000+ hospitals, cutting stroke transfer time by 44% in 2026 clinical data.

    • First FDA-cleared AI platform for stroke triage and large vessel occlusion detection
    • Alerts the entire care team simultaneously rather than one reader at a time
    • Trusted by more than 2,000 hospitals across the United States

    Pioneered FDA-cleared AI stroke triage with a long clinical track record

    Enterprise pricing requires a sales conversation, no published self-serve rate

    Visit Viz.ai (opens Viz.ai in a new tab)ReviewCompare with InHEART

  5. Artera

    4.4Not listed

    vs InHEART+0.2

    FDA-cleared multimodal AI that reads biopsy images and clinical data to guide cancer therapy decisions.

    • Multimodal AI trained on digitized biopsy images paired with clinical data
    • FDA De Novo authorization for the ArteraAI Prostate Test
    • FDA clearance for ArteraAI Breast digital pathology risk stratification

    Regulatory clearance (FDA De Novo, NCCN guideline inclusion) beyond most AI health startups

    Not a self-serve software product; access runs through labs, clinicians, and insurance billing

    Visit Artera (opens Artera in a new tab)ReviewCompare with InHEART

  6. PathAI

    4.3Not listed

    vs InHEART+0.1

    First AI pathology platform FDA-cleared for primary diagnosis, now deployed nationwide via Labcorp.

    • AISight Dx analyzes digital pathology slide images to assist diagnosis
    • FDA 510(k) clearance for primary diagnosis in clinical settings, June 2025
    • Predetermined Change Control Plan allows faster future software updates

    Genuine FDA clearance for primary diagnosis, not just an assistive tool

    Enterprise quote-based pricing requires a sales conversation, no published rates

    Visit PathAI (opens PathAI in a new tab)ReviewCompare with InHEART

  7. Ezra AI

    4.1$499/mo

    vs InHEART−0.1

    Full-body MRI screening service that uses AI to flag early signs of cancer across up to 13 organs.

    • Full-body MRI scanning covering up to 13 organs in a single visit
    • Ezra Flash AI image enhancement to improve scan clarity
    • Ezra Assist AI-supported radiologist review, FDA-cleared for prostate imaging

    AI-assisted imaging pipeline layered on top of licensed radiologist review, not a replacement for one

    Now operates as a subsidiary of Function Health rather than an independent company, which may affect long-term product direction

    Visit Ezra AI (opens Ezra AI in a new tab)ReviewCompare with InHEART

  8. Oatmeal Health

    3.3Not listed

    vs InHEART−0.9

    AI reads 3D low-dose CT scans and risk-stratifies lung nodules (AUROC 0.94, trained on 100,000+ scans) - already deployed across underserved health centers in 4 states.

    • AI risk-stratification of lung nodules from 3D low-dose CT
    • AUROC 0.94, trained on 100,000+ CT scans
    • Complements established Lung-RADS protocols

    Real, verifiable clinical deployment, not just a pilot announcement

    LungAI is an investigational device and has not yet been cleared by the FDA - a 510(k) submission is targeted for Q1 2026

    Visit Oatmeal Health (opens Oatmeal Health in a new tab)ReviewCompare with InHEART

FAQ

Questions people ask

Is InHEART free?

InHEART does not list a free plan. Check its pricing page for current plans.

What is the cheapest alternative to InHEART?

Among paid plans, Ezra AI has the lowest starting price (from $499/mo).

How did you pick these alternatives?

We match tools on what they do, their category and their price, using the details in our directory. Ratings come from our reviews and reader reviews.